Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Traffic & App Usage Insights

Discover domain traffic and app usage trends for companies and their competitors.

Last Close
Oct 04 04:00PM ET
32.02
Dollar change
-0.08
Percentage change
-0.25
%
IndexRUT P/E362.63 EPS (ttm)0.09 Insider Own4.25% Shs Outstand54.72M Perf Week4.13%
Market Cap1.76B Forward P/E17.56 EPS next Y1.82 Insider Trans-0.59% Shs Float52.76M Perf Month-6.86%
Income5.24M PEG214.57 EPS next Q0.44 Inst Own107.89% Short Float12.88% Perf Quarter22.03%
Sales630.16M P/S2.80 EPS this Y-14.94% Inst Trans4.04% Short Ratio15.32 Perf Half Y-4.56%
Book/sh17.39 P/B1.84 EPS next Y-8.83% ROA0.40% Short Interest6.80M Perf Year18.99%
Cash/sh6.30 P/C5.08 EPS next 5Y1.69% ROE0.56% 52W Range21.99 - 35.44 Perf YTD10.64%
Dividend Est.- P/FCF11.43 EPS past 5Y-59.02% ROI0.53% 52W High-9.65% Beta0.87
Dividend TTM- Quick Ratio1.69 Sales past 5Y9.22% Gross Margin74.86% 52W Low45.61% ATR (14)0.91
Dividend Ex-Date- Current Ratio1.91 EPS Y/Y TTM-88.31% Oper. Margin6.45% RSI (14)50.67 Volatility2.78% 3.01%
Employees652 Debt/Eq0.04 Sales Y/Y TTM-0.61% Profit Margin0.83% Recom2.00 Target Price39.25
Option/ShortYes / Yes LT Debt/Eq0.03 EPS Q/Q2451.32% Payout0.00% Rel Volume0.37 Prev Close32.10
Sales Surprise13.10% EPS Surprise94.92% Sales Q/Q24.17% EarningsAug 06 AMC Avg Volume443.64K Price32.02
SMA200.98% SMA50-0.90% SMA2006.84% Trades Volume163,741 Change-0.25%
Date Action Analyst Rating Change Price Target Change
Sep-11-24Downgrade Piper Sandler Overweight → Neutral $41 → $36
Jan-03-23Resumed Jefferies Buy $44 → $45
Dec-01-21Resumed Jefferies Buy $40 → $44
Apr-13-21Upgrade Jefferies Hold → Buy $25 → $40
Jun-16-20Upgrade Piper Sandler Neutral → Overweight $25 → $31
Jun-15-20Resumed Jefferies Hold $24
Nov-08-19Downgrade Berenberg Buy → Hold
Nov-07-19Downgrade Stifel Buy → Hold $55 → $23
Nov-06-19Downgrade Jefferies Buy → Hold $46 → $23
Nov-12-18Reiterated B. Riley FBR Buy $68 → $65
Sep-24-24 07:30AM
Sep-19-24 04:30PM
Sep-16-24 10:50AM
Sep-11-24 02:38PM
Aug-28-24 04:15PM
07:00AM Loading…
Aug-19-24 07:00AM
Aug-09-24 09:55AM
Aug-06-24 08:00PM
06:45PM
05:36PM
04:06PM
Aug-01-24 04:30PM
Jul-23-24 04:13PM
Jul-19-24 01:58PM
May-30-24 04:25PM
11:53AM Loading…
May-24-24 11:53AM
May-23-24 04:05PM
May-10-24 01:38PM
May-09-24 04:05PM
11:56AM
03:42AM
May-08-24 10:56PM
07:00PM
04:05PM
May-07-24 11:46AM
10:00AM
09:15AM
May-01-24 08:00AM
Apr-24-24 04:05PM
Apr-08-24 12:11PM
08:00AM Loading…
08:00AM
Mar-27-24 04:37PM
Mar-06-24 04:30PM
Mar-04-24 08:28PM
Feb-28-24 04:30PM
09:19AM
07:17AM
Feb-27-24 07:30PM
06:50PM
06:02PM
05:00PM
04:05PM
Feb-26-24 09:15AM
Feb-20-24 10:00AM
Feb-13-24 04:05PM
Feb-05-24 08:30AM
Dec-19-23 07:30AM
Dec-14-23 07:43PM
Nov-18-23 05:03AM
Nov-10-23 12:10PM
Nov-09-23 09:54AM
Nov-08-23 07:30PM
07:15PM
06:08PM
04:05PM
Nov-07-23 04:30PM
Nov-02-23 07:00AM
Nov-01-23 10:01AM
Oct-25-23 04:15PM
Oct-16-23 05:34PM
Oct-09-23 04:45PM
Sep-27-23 04:15PM
Sep-26-23 07:37PM
Sep-09-23 08:00PM
Aug-31-23 05:30PM
Aug-21-23 09:00AM
Aug-08-23 08:30PM
07:55PM
06:40PM
04:17PM
Jul-28-23 02:56PM
Jul-25-23 06:36AM
Jul-24-23 04:05PM
Jun-27-23 11:50AM
Jun-21-23 08:00PM
Jun-10-23 07:40AM
May-31-23 04:15PM
May-11-23 08:39AM
May-10-23 11:23AM
May-09-23 08:30PM
07:05PM
06:09PM
04:05PM
May-02-23 04:05PM
Apr-26-23 08:00PM
Apr-25-23 04:15PM
Apr-03-23 04:05PM
Mar-31-23 12:41PM
Mar-30-23 05:22PM
Mar-08-23 04:05PM
Mar-02-23 08:29PM
Mar-01-23 04:55PM
05:50AM
Feb-28-23 05:25PM
04:05PM
Feb-21-23 10:00AM
Feb-14-23 04:30PM
09:27AM
Feb-09-23 06:15PM
Jan-18-23 08:11AM
Supernus Pharmaceuticals, Inc. engages in the development and commercialization of products for the treatment of central nervous system diseases. It offers Trokendi XR, Oxtellar XR, APOKYN, XADAGO, and MYOBLOC products. The company was founded by Jack A. Khattar on March 30, 2005, and is headquartered in Rockville, MD.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
GEMAYEL GEORGESDirectorSep 13 '24Option Exercise11.4610,000114,60023,315Sep 17 04:10 PM
GEMAYEL GEORGESDirectorSep 13 '24Sale31.3313,886435,04813,315Sep 17 04:10 PM
GEORGES GEMAYELDirectorSep 13 '24Proposed Sale31.3313,886435,041Sep 13 04:30 PM
Khattar Jack A.President, CEOSep 03 '24Option Exercise0.0021,0000936,217Sep 03 05:00 PM
Bhatt Padmanabh P.Sr. VP of IP, CSOAug 20 '24Option Exercise0.001,250010,251Aug 20 05:00 PM
TAMI TILLOTSON MARTINFormer OfficerAug 02 '24Proposed Sale29.024,000116,074Aug 02 04:16 PM
TAMI TILLOTSON MARTINFormer OfficerAug 01 '24Proposed Sale29.313,10090,856Aug 01 04:19 PM
TAMI TILLOTSON MARTINFormer OfficerJul 31 '24Proposed Sale30.135,000150,650Jul 31 04:41 PM
TAMI TILLOTSON MARTINFormer OfficerJul 30 '24Proposed Sale30.562,90088,610Jul 30 04:02 PM
TAMI TILLOTSON MARTINFormer OfficerJul 29 '24Proposed Sale30.755,000153,750Jul 29 04:08 PM
Bhatt Padmanabh P.Sr. VP of IP, CSOMar 21 '24Option Exercise25.3014,491366,62223,061Mar 25 05:00 PM
Bhatt Padmanabh P.Sr. VP of IP, CSOMar 21 '24Sale35.3114,491511,6778,570Mar 25 05:00 PM
Bhatt Padmanabh P.Sr. VP of IP, CSOMar 20 '24Option Exercise25.3040010,1208,970Mar 22 05:00 PM
Bhatt Padmanabh P.Sr. VP of IP, CSOMar 20 '24Sale35.3140014,1248,570Mar 22 05:00 PM
Bhatt Padmanabh P.Sr. VP of IP, CSOMar 19 '24Option Exercise25.3012,364312,80920,934Mar 21 05:01 PM
Bhatt Padmanabh P.Sr. VP of IP, CSOMar 19 '24Sale35.3112,364436,5738,570Mar 21 05:01 PM
Bhatt Padmanabh P.Sr. VP of IP, CSOMar 13 '24Option Exercise17.6162,3661,098,52344,686Mar 15 06:39 PM
Bhatt Padmanabh P.Sr. VP of IP, CSOMar 13 '24Sale33.7462,3662,104,2898,570Mar 15 06:39 PM
Bhatt Padmanabh P.Sr. VP of IP, CSOMar 12 '24Option Exercise12.983,88450,41412,454Mar 14 05:00 PM
Bhatt Padmanabh P.Sr. VP of IP, CSOMar 12 '24Sale32.993,884128,1338,570Mar 14 05:00 PM
Mottola FrankSVP, Quality, GMP, Ops, ITFeb 28 '24Option Exercise0.0099008,239Feb 29 05:01 PM
Khattar Jack A.President, CEOFeb 28 '24Option Exercise0.0035,0000932,005Feb 29 05:00 PM
Bhatt Padmanabh P.Sr. VP of IP, CSOFeb 26 '24Option Exercise9.135,00045,65013,570Feb 28 05:01 PM
Bhatt Padmanabh P.Sr. VP of IP, CSOFeb 26 '24Sale30.215,000151,0508,570Feb 28 05:01 PM
Martin Tami TillotsonSr. V.P., Regulatory AffairsJan 10 '24Option Exercise9.248,00073,92093,664Jan 12 05:00 PM
Martin Tami TillotsonSr. V.P., Regulatory AffairsJan 10 '24Sale27.918,000223,28085,664Jan 12 05:00 PM
Rubin JonathanSr. VP, Chief Medical OfficerDec 22 '23Option Exercise0.0060003,447Dec 26 05:01 PM
Khattar Jack A.President, CEODec 22 '23Option Exercise0.0025,0000892,463Dec 26 05:00 PM
NEWHALL CHARLES W IIIDirectorNov 16 '23Option Exercise9.247,45768,903119,589Nov 20 05:00 PM
NEWHALL CHARLES W IIIDirectorNov 16 '23Sale28.012,50070,025117,089Nov 20 05:00 PM
Hudson Frederick M.DirectorNov 15 '23Option Exercise9.247,45768,90342,324Nov 17 05:00 PM
Hudson Frederick M.DirectorNov 15 '23Sale28.509,093259,15033,231Nov 17 05:00 PM
Mottola FrankSVP, Quality, GMP, Ops, ITNov 14 '23Option Exercise9.242,00018,4806,791Nov 16 05:00 PM
Mottola FrankSVP, Quality, GMP, Ops, ITNov 14 '23Sale28.131,11031,2245,681Nov 16 05:00 PM
DEC TIMOTHY CSenior Vice-President & CFOOct 13 '23Option Exercise0.004,00007,000Oct 13 05:00 PM